JP2009533472A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009533472A5 JP2009533472A5 JP2009505614A JP2009505614A JP2009533472A5 JP 2009533472 A5 JP2009533472 A5 JP 2009533472A5 JP 2009505614 A JP2009505614 A JP 2009505614A JP 2009505614 A JP2009505614 A JP 2009505614A JP 2009533472 A5 JP2009533472 A5 JP 2009533472A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- group
- halo
- alkoxy
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 CCC=*C=C1C(N[U])=NC(O)=NC1=* Chemical compound CCC=*C=C1C(N[U])=NC(O)=NC1=* 0.000 description 2
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US79184106P | 2006-04-13 | 2006-04-13 | |
| PCT/US2007/066478 WO2007121279A2 (en) | 2006-04-13 | 2007-04-12 | Cancer treatment method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009533472A JP2009533472A (ja) | 2009-09-17 |
| JP2009533472A5 true JP2009533472A5 (enExample) | 2010-05-20 |
Family
ID=38610376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009505614A Pending JP2009533472A (ja) | 2006-04-13 | 2007-04-12 | 癌治療法 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20090203718A1 (enExample) |
| EP (1) | EP2012587A2 (enExample) |
| JP (1) | JP2009533472A (enExample) |
| WO (1) | WO2007121279A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2011146339A (ru) * | 2009-04-16 | 2013-05-27 | Мерк Шарп Энд Домэ Корп. | Комбинированная терапия с использованием агента (ов) против igfr и специфических ингибиторов igf-1r |
| EP2475789A4 (en) * | 2009-09-09 | 2013-12-18 | Quintiles Transnat Corp | METHOD FOR PREDICTING THE RESPONSIBILITY OF A DISEASE OR A SLEEPING TO A RECEPTOR SYRINOIN INHIBITORY BY ANALYSIS OF MUTATIONS IN PIK3CA |
| EP2550269B1 (en) | 2010-03-23 | 2016-03-23 | Scinopharm Taiwan Ltd. | Process and intermediates for preparing lapatinib |
| WO2012026511A1 (ja) * | 2010-08-27 | 2012-03-01 | 協和発酵キリン株式会社 | 医薬組成物 |
| ITMI20110894A1 (it) * | 2011-05-20 | 2012-11-21 | Italiana Sint Spa | Impurezza del lapatinib e suoi sali |
| WO2014170910A1 (en) | 2013-04-04 | 2014-10-23 | Natco Pharma Limited | Process for the preparation of lapatinib |
| CA3129665A1 (en) | 2019-03-21 | 2020-09-24 | Onxeo | A dbait molecule in combination with kinase inhibitor for the treatment of cancer |
| KR20220098759A (ko) | 2019-11-08 | 2022-07-12 | 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) | 키나제 억제제에 대해 내성을 획득한 암의 치료 방법 |
| WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS49779B (sr) * | 1998-01-12 | 2008-06-05 | Glaxo Group Limited, | Biciklična heteroaromatična jedinjenja kao inhibitori protein tirozin kinaze |
| CA2413134C (en) * | 2000-06-30 | 2010-05-11 | Glaxo Group Limited | Quinazoline ditosylate salt compounds |
| TWI238824B (en) * | 2001-05-14 | 2005-09-01 | Novartis Ag | 4-amino-5-phenyl-7-cyclobutyl-pyrrolo[2,3-d]pyrimidine derivatives |
| WO2005082415A2 (en) * | 2004-02-25 | 2005-09-09 | Dana Farber Cancer Institute, Inc. | Inhibitors of insulin-like growth factor receptor-1 for inhibiting tumor cell growth |
| EP1796711A2 (en) * | 2004-04-22 | 2007-06-20 | Oregon Health and Science University | Herstatin or intron 8-encoded domain thereof for modulating signaling mediated by igf-1 receptor and erbb receptors |
-
2006
- 2006-04-13 US US12/296,972 patent/US20090203718A1/en not_active Abandoned
-
2007
- 2007-04-12 EP EP07781778A patent/EP2012587A2/en not_active Withdrawn
- 2007-04-12 WO PCT/US2007/066478 patent/WO2007121279A2/en not_active Ceased
- 2007-04-12 JP JP2009505614A patent/JP2009533472A/ja active Pending